Anne Coleman to Programmed Cell Death 1 Receptor
This is a "connection" page, showing publications Anne Coleman has written about Programmed Cell Death 1 Receptor.
Connection Strength
0.069
-
Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmology. 2021 06; 128(6):910-919.
Score: 0.044
-
Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy. Clin Exp Immunol. 2012 Nov; 170(2):212-21.
Score: 0.025